 | • レポートコード：MRC308GR11495 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の経口血糖降下薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の経口血糖降下薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 経口血糖降下薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
経口血糖降下薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ビグアナイド類、スルホニルウレア剤、メグリチニド類、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤、SGLT2阻害剤、チアゾリジンジオン、α-グルコシダーゼ阻害剤、その他
用途別セグメント
・病院、クリニック、その他
主要な市場プレーヤー
・Bayer、Merck、Novartis、Huadong Medicine、Sanofi、Novo Nordisk、Servier、Takeda Pharmaceutical、Luye Pharmaceutical、Taiji Group、CR Double-Crane、AstraZeneca、Boehringer Ingelheim、Qilu Pharmaceutical、Jiangsu Deyuan Pharmaceutical、CTTQ
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、経口血糖降下薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口血糖降下薬メーカーの企業概要、2019年～2022年までの経口血糖降下薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口血糖降下薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別経口血糖降下薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの経口血糖降下薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での経口血糖降下薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および経口血糖降下薬の産業チェーンを掲載しています。
・第14、15章では、経口血糖降下薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 経口血糖降下薬の概要
– 種類別分析（2018年vs2022年vs2029年）：ビグアナイド類、スルホニルウレア剤、メグリチニド類、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤、SGLT2阻害剤、チアゾリジンジオン、α-グルコシダーゼ阻害剤、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、クリニック、その他
– 世界の経口血糖降下薬市場規模・予測
– 世界の経口血糖降下薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bayer、Merck、Novartis、Huadong Medicine、Sanofi、Novo Nordisk、Servier、Takeda Pharmaceutical、Luye Pharmaceutical、Taiji Group、CR Double-Crane、AstraZeneca、Boehringer Ingelheim、Qilu Pharmaceutical、Jiangsu Deyuan Pharmaceutical、CTTQ
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ビグアナイド類、スルホニルウレア剤、メグリチニド類、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤、SGLT2阻害剤、チアゾリジンジオン、α-グルコシダーゼ阻害剤、その他
・用途別分析2018年-2029年：病院、クリニック、その他
・経口血糖降下薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口血糖降下薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口血糖降下薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口血糖降下薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・経口血糖降下薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Oral Hypoglycemic Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Hypoglycemic Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Biguanides
1.3.3 Sulfonylureas
1.3.4 Meglitinides
1.3.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
1.3.6 SGLT2 Inhibitors
1.3.7 Thiazolidinediones
1.3.8 Alpha-Glucosidase Inhibitors
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Hypoglycemic Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Oral Hypoglycemic Medications Market Size & Forecast
1.5.1 Global Oral Hypoglycemic Medications Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral Hypoglycemic Medications Sales Quantity (2018-2029)
1.5.3 Global Oral Hypoglycemic Medications Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Oral Hypoglycemic Medications Product and Services
2.1.4 Bayer Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Oral Hypoglycemic Medications Product and Services
2.2.4 Merck Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Oral Hypoglycemic Medications Product and Services
2.3.4 Novartis Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 Huadong Medicine
2.4.1 Huadong Medicine Details
2.4.2 Huadong Medicine Major Business
2.4.3 Huadong Medicine Oral Hypoglycemic Medications Product and Services
2.4.4 Huadong Medicine Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Huadong Medicine Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Oral Hypoglycemic Medications Product and Services
2.5.4 Sanofi Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Oral Hypoglycemic Medications Product and Services
2.6.4 Novo Nordisk Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novo Nordisk Recent Developments/Updates
2.7 Servier
2.7.1 Servier Details
2.7.2 Servier Major Business
2.7.3 Servier Oral Hypoglycemic Medications Product and Services
2.7.4 Servier Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Servier Recent Developments/Updates
2.8 Takeda Pharmaceutical
2.8.1 Takeda Pharmaceutical Details
2.8.2 Takeda Pharmaceutical Major Business
2.8.3 Takeda Pharmaceutical Oral Hypoglycemic Medications Product and Services
2.8.4 Takeda Pharmaceutical Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Recent Developments/Updates
2.9 Luye Pharmaceutical
2.9.1 Luye Pharmaceutical Details
2.9.2 Luye Pharmaceutical Major Business
2.9.3 Luye Pharmaceutical Oral Hypoglycemic Medications Product and Services
2.9.4 Luye Pharmaceutical Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Luye Pharmaceutical Recent Developments/Updates
2.10 Taiji Group
2.10.1 Taiji Group Details
2.10.2 Taiji Group Major Business
2.10.3 Taiji Group Oral Hypoglycemic Medications Product and Services
2.10.4 Taiji Group Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Taiji Group Recent Developments/Updates
2.11 CR Double-Crane
2.11.1 CR Double-Crane Details
2.11.2 CR Double-Crane Major Business
2.11.3 CR Double-Crane Oral Hypoglycemic Medications Product and Services
2.11.4 CR Double-Crane Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CR Double-Crane Recent Developments/Updates
2.12 AstraZeneca
2.12.1 AstraZeneca Details
2.12.2 AstraZeneca Major Business
2.12.3 AstraZeneca Oral Hypoglycemic Medications Product and Services
2.12.4 AstraZeneca Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AstraZeneca Recent Developments/Updates
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Oral Hypoglycemic Medications Product and Services
2.13.4 Boehringer Ingelheim Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Boehringer Ingelheim Recent Developments/Updates
2.14 Qilu Pharmaceutical
2.14.1 Qilu Pharmaceutical Details
2.14.2 Qilu Pharmaceutical Major Business
2.14.3 Qilu Pharmaceutical Oral Hypoglycemic Medications Product and Services
2.14.4 Qilu Pharmaceutical Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Qilu Pharmaceutical Recent Developments/Updates
2.15 Jiangsu Deyuan Pharmaceutical
2.15.1 Jiangsu Deyuan Pharmaceutical Details
2.15.2 Jiangsu Deyuan Pharmaceutical Major Business
2.15.3 Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Product and Services
2.15.4 Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
2.16 CTTQ
2.16.1 CTTQ Details
2.16.2 CTTQ Major Business
2.16.3 CTTQ Oral Hypoglycemic Medications Product and Services
2.16.4 CTTQ Oral Hypoglycemic Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 CTTQ Recent Developments/Updates
3 Competitive Environment: Oral Hypoglycemic Medications by Manufacturer
3.1 Global Oral Hypoglycemic Medications Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral Hypoglycemic Medications Revenue by Manufacturer (2018-2023)
3.3 Global Oral Hypoglycemic Medications Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral Hypoglycemic Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral Hypoglycemic Medications Manufacturer Market Share in 2022
3.4.2 Top 6 Oral Hypoglycemic Medications Manufacturer Market Share in 2022
3.5 Oral Hypoglycemic Medications Market: Overall Company Footprint Analysis
3.5.1 Oral Hypoglycemic Medications Market: Region Footprint
3.5.2 Oral Hypoglycemic Medications Market: Company Product Type Footprint
3.5.3 Oral Hypoglycemic Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Hypoglycemic Medications Market Size by Region
4.1.1 Global Oral Hypoglycemic Medications Sales Quantity by Region (2018-2029)
4.1.2 Global Oral Hypoglycemic Medications Consumption Value by Region (2018-2029)
4.1.3 Global Oral Hypoglycemic Medications Average Price by Region (2018-2029)
4.2 North America Oral Hypoglycemic Medications Consumption Value (2018-2029)
4.3 Europe Oral Hypoglycemic Medications Consumption Value (2018-2029)
4.4 Asia-Pacific Oral Hypoglycemic Medications Consumption Value (2018-2029)
4.5 South America Oral Hypoglycemic Medications Consumption Value (2018-2029)
4.6 Middle East and Africa Oral Hypoglycemic Medications Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
5.2 Global Oral Hypoglycemic Medications Consumption Value by Type (2018-2029)
5.3 Global Oral Hypoglycemic Medications Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
6.2 Global Oral Hypoglycemic Medications Consumption Value by Application (2018-2029)
6.3 Global Oral Hypoglycemic Medications Average Price by Application (2018-2029)
7 North America
7.1 North America Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
7.2 North America Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
7.3 North America Oral Hypoglycemic Medications Market Size by Country
7.3.1 North America Oral Hypoglycemic Medications Sales Quantity by Country (2018-2029)
7.3.2 North America Oral Hypoglycemic Medications Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
8.2 Europe Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
8.3 Europe Oral Hypoglycemic Medications Market Size by Country
8.3.1 Europe Oral Hypoglycemic Medications Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral Hypoglycemic Medications Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral Hypoglycemic Medications Market Size by Region
9.3.1 Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral Hypoglycemic Medications Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
10.2 South America Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
10.3 South America Oral Hypoglycemic Medications Market Size by Country
10.3.1 South America Oral Hypoglycemic Medications Sales Quantity by Country (2018-2029)
10.3.2 South America Oral Hypoglycemic Medications Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral Hypoglycemic Medications Market Size by Country
11.3.1 Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral Hypoglycemic Medications Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral Hypoglycemic Medications Market Drivers
12.2 Oral Hypoglycemic Medications Market Restraints
12.3 Oral Hypoglycemic Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Hypoglycemic Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Hypoglycemic Medications
13.3 Oral Hypoglycemic Medications Production Process
13.4 Oral Hypoglycemic Medications Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Hypoglycemic Medications Typical Distributors
14.3 Oral Hypoglycemic Medications Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Oral Hypoglycemic Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Hypoglycemic Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Oral Hypoglycemic Medications Product and Services
Table 6. Bayer Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Oral Hypoglycemic Medications Product and Services
Table 11. Merck Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Oral Hypoglycemic Medications Product and Services
Table 16. Novartis Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 19. Huadong Medicine Major Business
Table 20. Huadong Medicine Oral Hypoglycemic Medications Product and Services
Table 21. Huadong Medicine Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Huadong Medicine Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Oral Hypoglycemic Medications Product and Services
Table 26. Sanofi Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 29. Novo Nordisk Major Business
Table 30. Novo Nordisk Oral Hypoglycemic Medications Product and Services
Table 31. Novo Nordisk Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novo Nordisk Recent Developments/Updates
Table 33. Servier Basic Information, Manufacturing Base and Competitors
Table 34. Servier Major Business
Table 35. Servier Oral Hypoglycemic Medications Product and Services
Table 36. Servier Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Servier Recent Developments/Updates
Table 38. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Major Business
Table 40. Takeda Pharmaceutical Oral Hypoglycemic Medications Product and Services
Table 41. Takeda Pharmaceutical Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Recent Developments/Updates
Table 43. Luye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Luye Pharmaceutical Major Business
Table 45. Luye Pharmaceutical Oral Hypoglycemic Medications Product and Services
Table 46. Luye Pharmaceutical Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Luye Pharmaceutical Recent Developments/Updates
Table 48. Taiji Group Basic Information, Manufacturing Base and Competitors
Table 49. Taiji Group Major Business
Table 50. Taiji Group Oral Hypoglycemic Medications Product and Services
Table 51. Taiji Group Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Taiji Group Recent Developments/Updates
Table 53. CR Double-Crane Basic Information, Manufacturing Base and Competitors
Table 54. CR Double-Crane Major Business
Table 55. CR Double-Crane Oral Hypoglycemic Medications Product and Services
Table 56. CR Double-Crane Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CR Double-Crane Recent Developments/Updates
Table 58. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 59. AstraZeneca Major Business
Table 60. AstraZeneca Oral Hypoglycemic Medications Product and Services
Table 61. AstraZeneca Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. AstraZeneca Recent Developments/Updates
Table 63. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Major Business
Table 65. Boehringer Ingelheim Oral Hypoglycemic Medications Product and Services
Table 66. Boehringer Ingelheim Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Qilu Pharmaceutical Major Business
Table 70. Qilu Pharmaceutical Oral Hypoglycemic Medications Product and Services
Table 71. Qilu Pharmaceutical Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Qilu Pharmaceutical Recent Developments/Updates
Table 73. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Deyuan Pharmaceutical Major Business
Table 75. Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Product and Services
Table 76. Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 78. CTTQ Basic Information, Manufacturing Base and Competitors
Table 79. CTTQ Major Business
Table 80. CTTQ Oral Hypoglycemic Medications Product and Services
Table 81. CTTQ Oral Hypoglycemic Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. CTTQ Recent Developments/Updates
Table 83. Global Oral Hypoglycemic Medications Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Oral Hypoglycemic Medications Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Oral Hypoglycemic Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Oral Hypoglycemic Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Oral Hypoglycemic Medications Production Site of Key Manufacturer
Table 88. Oral Hypoglycemic Medications Market: Company Product Type Footprint
Table 89. Oral Hypoglycemic Medications Market: Company Product Application Footprint
Table 90. Oral Hypoglycemic Medications New Market Entrants and Barriers to Market Entry
Table 91. Oral Hypoglycemic Medications Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Oral Hypoglycemic Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Oral Hypoglycemic Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Oral Hypoglycemic Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Oral Hypoglycemic Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Oral Hypoglycemic Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Oral Hypoglycemic Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Oral Hypoglycemic Medications Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Oral Hypoglycemic Medications Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Oral Hypoglycemic Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Oral Hypoglycemic Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Oral Hypoglycemic Medications Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Oral Hypoglycemic Medications Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Oral Hypoglycemic Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Oral Hypoglycemic Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Oral Hypoglycemic Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Oral Hypoglycemic Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Oral Hypoglycemic Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Oral Hypoglycemic Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Oral Hypoglycemic Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Oral Hypoglycemic Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Oral Hypoglycemic Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Oral Hypoglycemic Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Oral Hypoglycemic Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Oral Hypoglycemic Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Oral Hypoglycemic Medications Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Oral Hypoglycemic Medications Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Oral Hypoglycemic Medications Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Oral Hypoglycemic Medications Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Oral Hypoglycemic Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Oral Hypoglycemic Medications Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Oral Hypoglycemic Medications Raw Material
Table 151. Key Manufacturers of Oral Hypoglycemic Medications Raw Materials
Table 152. Oral Hypoglycemic Medications Typical Distributors
Table 153. Oral Hypoglycemic Medications Typical Customers
List of Figures
Figure 1. Oral Hypoglycemic Medications Picture
Figure 2. Global Oral Hypoglycemic Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Hypoglycemic Medications Consumption Value Market Share by Type in 2022
Figure 4. Biguanides Examples
Figure 5. Sulfonylureas Examples
Figure 6. Meglitinides Examples
Figure 7. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Examples
Figure 8. SGLT2 Inhibitors Examples
Figure 9. Thiazolidinediones Examples
Figure 10. Alpha-Glucosidase Inhibitors Examples
Figure 11. Other Examples
Figure 12. Global Oral Hypoglycemic Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Oral Hypoglycemic Medications Consumption Value Market Share by Application in 2022
Figure 14. Hospital Examples
Figure 15. Clinic Examples
Figure 16. Other Examples
Figure 17. Global Oral Hypoglycemic Medications Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Oral Hypoglycemic Medications Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Oral Hypoglycemic Medications Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Oral Hypoglycemic Medications Average Price (2018-2029) & (US$/Unit)
Figure 21. Global Oral Hypoglycemic Medications Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Oral Hypoglycemic Medications Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Oral Hypoglycemic Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Oral Hypoglycemic Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Oral Hypoglycemic Medications Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Oral Hypoglycemic Medications Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Oral Hypoglycemic Medications Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Oral Hypoglycemic Medications Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Oral Hypoglycemic Medications Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Oral Hypoglycemic Medications Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Oral Hypoglycemic Medications Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Oral Hypoglycemic Medications Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Oral Hypoglycemic Medications Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Oral Hypoglycemic Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. Global Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Oral Hypoglycemic Medications Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Oral Hypoglycemic Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 39. North America Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Oral Hypoglycemic Medications Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Oral Hypoglycemic Medications Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Oral Hypoglycemic Medications Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Oral Hypoglycemic Medications Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Oral Hypoglycemic Medications Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Oral Hypoglycemic Medications Consumption Value Market Share by Region (2018-2029)
Figure 59. China Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Oral Hypoglycemic Medications Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Oral Hypoglycemic Medications Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Oral Hypoglycemic Medications Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Oral Hypoglycemic Medications Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Oral Hypoglycemic Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Oral Hypoglycemic Medications Market Drivers
Figure 80. Oral Hypoglycemic Medications Market Restraints
Figure 81. Oral Hypoglycemic Medications Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Oral Hypoglycemic Medications in 2022
Figure 84. Manufacturing Process Analysis of Oral Hypoglycemic Medications
Figure 85. Oral Hypoglycemic Medications Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source